Bone Marrow Diseases  >>  evofosfamide (IMGS-101)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
evofosfamide (IMGS-101) / Molecular Templates, ImmunoGenesis
NCT01149915: Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias

Completed
1
40
US
TH-302
Threshold Pharmaceuticals
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, High-risk Myelodysplastic Syndrome, Chronic Lymphocytic Leukemia, Advanced Myelofibrosis
08/13
08/13

Download Options